DACHF (Daicel) Stock Based Compensation: $0 Mil (TTM As of Mar. 2026)


DACHF Daicel Corp DACHF
82 GF Score
Price $8.00
GF Value $10.01
Valuation Modestly Undervalued
! 8 Warning Signs
View Full Analysis

What is Daicel Stock Based Compensation?

Daicel DACHF -0.12% 82 Stock Based Compensation is $0 Mil as of Mar. 2026. GuruFocus rates DACHF with a GF Score™ of 82/100 and a GF Value™ of $10.01 (Modestly Undervalued). The stock has 8 warning signs investors should review.

Daicel's Stock Based Compensation for the three months ended in Mar. 2026 was $0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 was $0 Mil.

Daicel Stock Based Compensation Related Terms

Daicel Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Daicel's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Daicel Stock Based Compensation Chart

Daicel Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Daicel Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
DACHF
82GF Score
Daicel Corp DACHF
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Daicel Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

What does a Stock Based Compensation of $0 Mil mean?
Daicel (DACHF) has a Stock Based Compensation of $0 Mil as of Mar. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Daicel and its competitors.
Is Daicel's Stock Based Compensation too high?
Daicel's current Stock Based Compensation is $0 Mil. Overall, Daicel has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Daicel's Stock Based Compensation compare to LIN and SHW?
Daicel's Stock Based Compensation of $0 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Chemicals company?
A good Stock Based Compensation depends on the Chemicals industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Daicel and its competitors. Daicel's current Stock Based Compensation is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Daicel stock overvalued right now?
Based on GuruFocus' analysis, Daicel (DACHF) is currently considered Modestly Undervalued. The stock's GF Value™ is $10.01, compared to a current price of $8.00 — trading 20.1% below its estimated fair value. The current Stock Based Compensation is $0 Mil. Daicel's overall GF Score™ is 82/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Daicel (DACHF), the current Stock Based Compensation is $0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Daicel (DACHF) Overvalued in 2026?

Based on GuruFocus' analysis, Daicel stock appears to be undervalued. The current stock price of $8.00 is trading 20.1% below its estimated GF Value™ of $10.01. GuruFocus considers Daicel to be Modestly Undervalued.

Key valuation signals for DACHF:

  • Stock Based Compensation: $0 Mil
  • GF Value™: $10.01 vs. price of $8.00 (20.1% below fair value)
  • GF Score™: 82/100 with 8 warning signs

No single metric tells the full story. See the DACHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Daicel Business Description

Other Exchanges 4202:Japan9DC:Germany
Address 3-1 Ofukacho, Grand Front Osaka Tower B, Kita-ku, Osaka, JPN
Daicel Corp is a Japanese chemical company engaged in engineering plastics, materials, medical health care, safety, smart materials, & other businesses. The company operates through five segments. The Engineering Plastics segment includes polyacetal resins, PET resins, liquid crystal polymers, and related products. The Material segment covers acetic acid, derivatives, acetate tow, cellulose acetate, and cosmetic raw materials. The Medical Health Care segment provides enantiomer separation columns and health food materials. The Safety segment offers inflators for automobile airbags and circuit breakers, while the Smart segment handles caprolactone derivatives, epoxy compounds, semiconductor materials, and functional films. The Others segment includes membranes and transportation warehouses.
82GF Score

Get the complete analysis for DACHF

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$8.00
Price
$10.01
GF Value